Silver Book Fact

Survival rates for colon cancer went from 41 percent to 63 percent between 1975 and 1995.

Lichtenberg, Frank R. The Expanding Pharmaceutical Arsenal in the War on Cancer. National Bureau of Economic Research. February 2004; Working Paper No. 10328. http://www.nber.org/papers/w10328

Reference

Title
The Expanding Pharmaceutical Arsenal in the War on Cancer
Publication
National Bureau of Economic Research
Publication Date
February 2004
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The overall five-year survival rate for women with invasive breast cancer is now 89 percent.  
  • A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment…  
  • For women age 40 or older, timely mammograms could reduce breast cancer mortality by about 16%–compared to those who are not screened.  
  • A one percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and increased productivity from longer lives.  
  • According to the Pharmaceutical Research and Manufacturers of America, a number of vaccines are being studied that would cause the body’s own immune system to fight cancer after it has…